Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Clinical trial NCT03934372 · RECRUITING
Trial details
- NCT number
- NCT03934372
- Sponsor
- Incyte Biosciences International Sàrl
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-29
- Primary completion
- 2028-02-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.